Prakash Raman, Ph.D. has served as a member of our Board of Directors since April 2026. Since April 2024, Dr. Raman has served as Chief Executive Officer and a member of the board of directors of InduPro, Inc., a biotechnology company. From February 2022 to March 2024, Dr. Raman was President and Chief Executive Officer of Ribon Therapeutics, Inc., a biopharmaceutical company. Previously, from October 2019 to February 2022, Dr. Raman served as Senior Partner, Chief Business Development Officer at Flagship Pioneering, a venture capital company. Prior to that, Dr. Raman spent nearly fourteen years at Novartis AG, a pharmaceutical corporation, from 2005 until 2011 and from 2012 until October 2019, most recently as its Vice President, Global Head of Novartis Institutes for Biomedical Research Business Development and Licensing. From 2011 to 2012, Dr. Raman was Head of Project Management, Infectious Diseases at AstraZeneca plc, a biopharmaceutical company, and, from 1999 to 2005, a Senior Scientist at Millennium Pharmaceuticals, Inc. (now Takeda Oncology), a biopharmaceutical company. Dr. Raman has served as a member of the board of directors of Black Diamond Therapeutics, Inc., an oncology company, since April 2024. Dr. Raman received his M.S. from the Indian Institute of Technology in Bombay, India, his Ph.D. in Organic and Medicinal Chemistry from the University of Wisconsin-Madison, and was a post-doctoral fellow at The Scripps Research Institute. We believe that Dr. Raman is qualified to serve on our Board of Directors due to his deep knowledge in the areas of business development and corporate strategy and extensive operational and leadership experience in the biopharmaceutical industry.